Pharmaceutical Risk and Recall Services for Insurers

RQA provides an independent view of the risks associated with pharmaceutical manufacturers, importers and distributors, helping underwriting and risk teams understand potential recall exposure and the effectiveness of an insured’s controls.

Independent pharmaceutical risk insight to support underwriting and risk improvement

Pharmaceutical recalls can involve significant patient-safety, regulatory, operational and financial consequences. The extent of the exposure depends not only on the nature of the product issue, but also on where the product has been distributed, the populations affected, the company’s ability to trace impacted batches and how quickly the organisation can investigate, make decisions and communicate with stakeholders.

Understanding pharmaceutical product recall risk

Understanding the recall exposure presented by a pharmaceutical company requires more than a general review of its operations. Insurers need to understand what the company manufactures, imports or distributes; how product failures could affect patients; which markets and populations may be exposed; and whether the organisation has the systems and resources to identify, contain and manage an incident.

RQA can undertake focused pharmaceutical risk assessments and pre-loss reviews to help insurers evaluate areas including:

  • the nature and criticality of the products;
  • manufacturing and distribution arrangements;
  • sterile and non-sterile operations;
  • outsourced and contract-manufacturing dependencies;
  • Quality Management Systems;
  • GMP and GDP controls;
  • supplier and service-provider oversight;
  • contamination-control and sterility-assurance arrangements;
  • batch release and certification processes;
  • traceability and distribution data;
  • complaint, deviation and pharmacovigilance signals;
  • recall governance and escalation procedures;
  • crisis-management capabilities; and
  • previous incidents, recalls and regulatory findings.

Our pharmaceutical specialists identify material weaknesses, assess how well recall risks are controlled and recommend practical improvements. Findings can help underwriters ask more informed questions, distinguish between apparently similar risks and establish proportionate risk-improvement requirements.

Pharmaceutical expertise across the product lifecycle

RQA can support organisations involved in:

  • sterile and non-sterile pharmaceutical manufacturing;
  • biotechnology and biosimilars;
  • vaccines;
  • cell and gene therapies;
  • clinical-development and commercial products;
  • pharmaceutical importation;
  • storage, wholesale and distribution;
  • contract manufacturing and outsourced operations;
  • medical devices and combination products; and
  • pharmaceutical supply-chain services.

Our wider pharmaceutical capability includes quality systems, GMP and GDP compliance, audits, inspection readiness, contamination control, validation, pharmacovigilance, QP/RP support, batch certification and EU importation.

This allows us to consider recall risk in the context of the company’s broader quality, regulatory and operational arrangements.

Why choose RQA?

⋅ Product recall and crisis-management experts

RQA specialises in product recall, product risk and crisis management, supporting manufacturers, insurers and legal teams before and during product incidents.

⋅ Pharmaceutical and regulatory expertise

Our consultants bring experience across pharmaceutical quality assurance, manufacturing, distribution, GMP/GDP compliance, regulatory affairs and specialist QP/RP activities.

⋅ Support for insurers and insured companies

We understand the different requirements of underwriters, risk engineers, claims teams and pharmaceutical businesses. Our work translates technical pharmaceutical risks into clear findings, practical recommendations and proportionate risk improvements.

⋅ Practical, tailored delivery

Every assignment is scoped around the organisation’s products, supply chain, markets, regulatory responsibilities and existing level of preparedness.

⋅ Global support

RQA works internationally through a network of more than 150 experienced consultants, providing access to appropriate expertise across markets and disciplines.

⋅ Independent perspective

Our independent assessments help insurers and pharmaceutical companies identify weaknesses that may be difficult to recognise from inside an organisation.

Discuss your pharmaceutical recall risks

Whether you are underwriting a pharmaceutical product recall risk, reviewing the preparedness of an insured company or strengthening your own recall and crisis-management arrangements, RQA can help.

Tell us about the organisation, products, markets or risks you need to assess, and we will help define an appropriate scope of support.

RQA logo

If you would like more information or to speak with a product risk expert, please share your details below or call us on:
+44 (0)118 405 0192.